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Although mortality from breast cancer has generally been increasing worldwide, there have been recent reports of declining mortality in the UK, USA, Norway, Sweden and elsewhere (Blot et al., 1987; Tarone and Chu, 1992; Coleman et al., 1993; Ursin et al., 1994; Beral et al., 1995 Beral et al., , 1996 .
In this paper we report on mortality trends in different cohorts of women and different periods of time for 20 countries in Europe, North America, Australia and New Zealand.
Methods
Information on age-specific numbers of deaths from breast cancer and population data for 20 countries were obtained from the World Health Organization's Division of Epidemiological Surveillance and Health Situation and Trend Assessment. Data were provided for each year during the period 1950-92 in 5 year age groups. The countries were selected on the basis that data were available for at least the period 1960-90. During the period 1950-92 the coding of cause of death spanned the sixth to the ninth revision of the International Classification of Disease (ICD). Breast cancer mortality data used for this analysis were coded using the Basic Tabulation list of the ICD, according to the following codes: [ICD 6 and 7: A051 (WHO, 1949; WHO, 1957) , ICD 8: A054 (WHO, 1967), ICD 9: B113 (WHO, 1977) ].
Data were initially displayed using mortality rates at ages 30-79 age standardised against the world standard (Parkin et al., 1992) for the individual years that were available. Age, cohort of birth and period of death are not statistically independent, because when two are defined the third is automatically implied and attempts to model all three factors can lead to over parameterisation (Breslow and Day, 1987) .
In these analyses two separate models were derived for each country: an age-birth cohort and an age-period of death model. Log-linear Poisson models (Clayton and Schiffiers, 1987) were constructed using the statistical package EGRET (Statistics and Epidemiology Research Corporation, 1985 19B0 1970 1980 1990 1950 1906 1970 1980 1990 1950 1950 1970 19w 19i0 1950 1960 1970 1950 1990 Denmark 1970 19i0 1990 1950 10 1970 19i0 1990 1950 1 1970 1w 19i0 1950 19i 1970 1980 1990 New Zealand 19w 1970 19w 19i0 1950 19i0 1970 1980 1990 1950 19i0 1970 1980 190 Sweden Switzerland
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United States To explain the observed patterns in breast cancer mortality in downward trend in the percentage of women who were different birth cohorts of women, data on reproductive childless by age 40 for cohorts born after 1930. However, in factors in successive generations of women were sought, but two countries which showed no fall in cohort mortality only limited data were available (Council of Europe, 1990;  ratios, Belgium and Spain, the percentage of women childless Coleman et al., 1993) . Table I (OPCS, 1984) . In Sweden, additional rules were instituted by the National Central Bureau of Statistics (1983) in 1981 for cause of death coding which produced an artificial lowering of mortality, the effect being strongest amongst the older age groups. In Denmark changes in coding were introduced in 1966 when information from autopsies was included on the death certificate (Ewertz and Carstensen, 1988) , consequently, a decline in breast cancer mortality occurred in the oldest age groups due to other more common causes of death being coded. We are unaware of any other changes in cause of death coding that may affect these results. In limiting our analyses to women aged 30-79 the effect of these changes in coding practices should be minimised. Changes in cohort mortality ratios may be in part due to changes in childbearing patterns (childlessness, parity, age at first full-term pregnancy) for different birth cohorts of women. Blot et al. (1987) and Tarone and Chu (1992) Berrino et al. (1995) and this supports the data presented here of increasing mortality during the study period.
Increased survival can be achieved by early detection of tumours and effective treatment. Blot et al. (1987) concluded that for women aged less than 40, recent changes in the detection and management of breast cancer have contributed to a reduced mortality in young women in the United States. National policies to promote mammography screening have been established over the last two decades in some countries, although in most countries national screening programmes have only recently been introduced and therefore it is too early for any effect to be seen in mortality rates. Widespread use of adjuvant chemotherapy during the 1980s has been shown to be an effective treatment for breast cancer (Early Breast Cancer Trialists Collaborative Group, 1992) . It would seem that early effective treatment may be playing a part in the recent decline in mortality in England and Wales (Beral et al., 1995; Baum, 1995) and perhaps elsewhere; but the effects of such treatment are very recent.
